BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18533260)

  • 1. Malignant hematopoietic cell lines: in vitro models for the study of Waldenström's macroglobulinemia.
    Drexler HG; MacLeod RA
    Leuk Res; 2008 Nov; 32(11):1669-73. PubMed ID: 18533260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wayne State University Waldenstrom's Macroglobulinemia preclinical model for Waldenstrom's macroglobulinemia.
    Al-Katib AM; Mensah-Osman E; Aboukameel A; Mohammad R
    Semin Oncol; 2003 Apr; 30(2):313-7. PubMed ID: 12720160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of cell lines for the study of Waldenström's macroglobulinemia.
    Gertz M; Ansell S
    Leuk Res; 2008 Nov; 32(11):1648-9. PubMed ID: 18533257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of BCWM.1 cell line for Waldenström's macroglobulinemia with productive in vivo engraftment in SCID-hu mice.
    Ditzel Santos D; Ho AW; Tournilhac O; Hatjiharissi E; Leleu X; Xu L; Tassone P; Neri P; Hunter ZR; Chemaly MA; Branagan AR; Manning RJ; Patterson CJ; Moreau AS; Ciccarelli B; Adamia S; Kriangkum J; Kutok JL; Tai YT; Zhang J; Pilarski LM; Anderson KC; Munshi N; Treon SP
    Exp Hematol; 2007 Sep; 35(9):1366-75. PubMed ID: 17761288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics and cytogenetics of Waldenstrom's macroglobulinemia.
    Schop RF; Fonseca R
    Semin Oncol; 2003 Apr; 30(2):142-5. PubMed ID: 12720124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
    Vitolo U; Ferreri AJ; Montoto S
    Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Waldenström's macroglobulinemia with an uncommon presentation].
    Trueba F; Maslin J; Coutant G; Guymar S; Vigezzi JF; Desangles F; Nizou JY; Nicand E
    Ann Biol Clin (Paris); 2006; 64(1):73-5. PubMed ID: 16420993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis in Waldenström's macroglobulinemia.
    Terpos E; Tasidou A; Kastritis E; Eleftherakis-Papaiakovou E; Gavriatopoulou M; Migkou M; Dimopoulos MA
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):46-9. PubMed ID: 19362971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: potential biological and therapeutic implications.
    Paulus A; Chitta KS; Wallace PK; Advani PP; Akhtar S; Kuranz-Blake M; Ailawadhi S; Chanan-Khan AA
    PLoS One; 2015; 10(4):e0122338. PubMed ID: 25853860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal abnormalities in patients with Waldenström's macroglobulinemia with special reference to a Burkitt-type t(8;14).
    San Román C; Ferro T; Guzmán M; Odriozola J
    Cancer Genet Cytogenet; 1985 Oct; 18(2):155-8. PubMed ID: 3931901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propagation of Waldenström's macroglobulinemia cells in vitro and in severe combined immune deficient mice: utility as a preclinical drug screening model.
    al-Katib A; Mohammad R; Hamdan M; Mohamed AN; Dan M; Smith MR
    Blood; 1993 Jun; 81(11):3034-42. PubMed ID: 8499639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics in Waldenström's macroglobulinemia.
    Sacco A; Ghobrial IM; Roccaro AM
    Epigenomics; 2010 Oct; 2(5):691-6. PubMed ID: 22122052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of an animal model for Waldenström's macroglobulinemia.
    Tsingotjidou AS; Emmanouilides CE; Siotou E; Poutahidis T; Xagorari A; Loukopoulos P; Sotiropoulos D; Bekiari C; Doulberis M; Givissis P; Fassas A; Anagnostopoulos A
    Exp Hematol; 2009 Apr; 37(4):469-76. PubMed ID: 19302921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
    Owen RG
    Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences.
    Kriangkum J; Taylor BJ; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM
    Clin Cancer Res; 2007 Apr; 13(7):2005-13. PubMed ID: 17404080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial Waldenstrom's macroglobulinemia.
    McMaster ML
    Semin Oncol; 2003 Apr; 30(2):146-52. PubMed ID: 12720125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human Burkitt's lymphoma cell line carrying t(8;22) and t(14;18) translocations.
    Kiefer T; Schüler F; Knopp A; Wimmer M; Hirt C; Schaefer HE; Dölken G
    Ann Hematol; 2007 Nov; 86(11):821-30. PubMed ID: 17622530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual evolution of Waldenström's macroglobulinemia into osteolytic myeloma.
    Jondeau K; Alterescu R; Franc B; Davi F; Massé JM; Boukour S; Le Parc JM; Cramer EM
    Eur J Haematol; 2006 Jul; 77(1):74-9. PubMed ID: 16827885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waldenström's macroglobulinemia and large B-cell central nervous system lymphoma: a case report.
    Langevin JP; Bergsneider M; Yashar P; Makary RF
    Surg Neurol; 2008 Apr; 69(4):407-10. PubMed ID: 18262236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of giant group A marker chromosome in several Burkitt lymphoma and lymphoblastoid cell lines with Epstein-Barr virus from different origins (author's transl)].
    Wu B; Wu YQ; Li Y; Zeng Y; Wu M; Zhao ZH; Gong CH
    Zhonghua Zhong Liu Za Zhi; 1979; 1(2):91-5. PubMed ID: 233360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.